Business
VALEO PHARMA CLOSES PREVIOUSLY ANNOUNCED UPSIZED $15 MILLION BOUGHT DEAL PRIVATE PLACEMENT AND CONCURRENT $10 MILLION PRIVATE PLACEMENT FROM INVESTISSEMENT QUEBEC
VALEO PHARMA CLOSES PREVIOUSLY ANNOUNCED UPSIZED $15 MILLION BOUGHT DEAL PRIVATE PLACEMENT AND CONCURRENT $10 MILLION PRIVATE PLACEMENT FROM INVESTISSEMENT QUEBEC.
About this update from Valeo Pharma Inc.
[{"type":"text","content":"\n\n\n\nVALEO PHARMA CLOSES PREVIOUSLY ANNOUNCED UPSIZED $15 MILLION BOUGHT DEAL PRIVATE PLACEMENT AND CONCURRENT $10 MILLION PRIVATE PLACEMENT FROM INVESTISSEMENT QUEBEC\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\nVALEO PHARMA CLOSES PREVIOUSLY ANNOUNCED UPSIZED $15 MILLION BOUGHT DEAL PRIVATE PLACEMENT AND CONCURRENT $10 MILLION PRIVATE PLACEMENT FROM INVESTISSEMENT QUEBEC\nCanada NewsWire\nMONTREAL, Dec. 9, 2021\n\n\n\nNOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS\nMONTREAL, Dec. 9, 2021 /CNW Telbec/ -Valeo Pharma Inc. (CSE:VPH, OTCQB: VPHIF, FSE: VP2) (\"Valeo\" or the \"Company\"), a Canadian pharmaceutical company, is pleased to announce it has closed its previously announced upsized bought deal private placement (the \"Offering\") of $15.0 million aggregate principal amount of 12.0% convertible unsecured debentures (the \"Debentures\") of the Company due December 31, 2024 (the \"Maturity Date\") at a price of $1,000 (the \"Offering Price\") per Debenture, through a syndicate of underwriters led by Desjardins Capital Markets (the \"Lead Underwriter\"), acting as sole bookrunner, and including iA Private Wealth Inc., Leede Jones Gable Inc., Paradigm Capital Inc. and Research Capital Corporation (collectively, with the Lead Underwriter, the \"Underwriters\"). Valeo is also pleased to announce it has closed the previously announced concurrent $10.0 million private placement of convertible unsecured debentures issued on the same terms as those issuable pursuant ot the Offering with Investissement Québec (the \"Concurrent Private Placement\"), resulting in gross proceed from the Offering and Concurent Private Placement of $25.0 million to the Company.\n\n \n \n \n \n \n \n\n \n\"In the last few months, we have consolidated our product portfolio and transformed our organizational structure. This financing is in line with our development strategy and supports our current stro...